|
|
||||||||
From the Glaucoma Center, University of California San Diego, La Jolla, California.
PURPOSE. To examine the expression of five prostaglandin (PG) receptors, EP1, EP2, EP3, EP4, and FP and their corresponding mRNA transcripts in human sclera and cultured human scleral fibroblasts (HSFs).
METHODS. Primary cultures of HSFs were established from donor eyes. Also, sclera from human donor eyes was snap frozen and sectioned. Immunocytochemistry was performed on HSFs and tissue sections with subtype-specific antibodies to the EP1, EP2, EP3, EP4, and FP receptors. The presence of mRNA for the receptor subtypes was examined from total RNA obtained from human sclera and confirmed with restriction digest analysis.
RESULTS. Positive EP1 and FP receptor immunoreactivity was observed in fibroblasts within the sections from human sclera. In primary cultures of HSFs, EP1 and FP labeling was observed over the entire cell surface. EP2 immunoreactivity within HSFs was mostly present in the juxtanuclear region. RT-PCR analysis of total RNA isolated from human sclera and HSFs confirmed the presence of EP1, EP2, and FP receptor subtypes. The identity of the polymerase chain reaction products was confirmed by restriction enzyme analysis. No mRNA or immunoreactivity above basal levels was detected for the EP3 and EP4 prostanoid receptor subtypes in tissue sections or primary cultures.
CONCLUSIONS. The EP1, EP2, and FP receptor subtypes are present in HSFs, suggesting that these cells may respond to endogenous PGs and their structural analogues through interaction with these receptor subtypes.
This article has been cited by other articles:
![]() |
J. G. Crowston, C. A. Morris, J. D. Lindsey, and R. N. Weinreb Prostaglandin FP Receptors Do Not Contribute to 24-hour Intraocular Pressure Variation in Mice Invest. Ophthalmol. Vis. Sci., May 1, 2007; 48(5): 2095 - 2098. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. A. Bundey and P. A. Insel Adenylyl Cyclase 6 Overexpression Decreases the Permeability of Endothelial Monolayers via Preferential Enhancement of Prostacyclin Receptor Function Mol. Pharmacol., November 1, 2006; 70(5): 1700 - 1707. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Han and T. Wu Cyclooxygenase-2-derived Prostaglandin E2 Promotes Human Cholangiocarcinoma Cell Growth and Invasion through EP1 Receptor-mediated Activation of the Epidermal Growth Factor Receptor and Akt J. Biol. Chem., June 24, 2005; 280(25): 24053 - 24063. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Ota, H. Murata, E.-i. Sugimoto, M. Aihara, and M. Araie Prostaglandin Analogues and Mouse Intraocular Pressure: Effects of Tafluprost, Latanoprost, Travoprost, and Unoprostone, Considering 24-Hour Variation Invest. Ophthalmol. Vis. Sci., June 1, 2005; 46(6): 2006 - 2011. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. G. Crowston, J. D. Lindsey, M. Aihara, and R. N. Weinreb Effect of Latanoprost on Intraocular Pressure in Mice Lacking the Prostaglandin FP Receptor Invest. Ophthalmol. Vis. Sci., October 1, 2004; 45(10): 3555 - 3559. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-L. Su, J.-Y. Shih, M.-L. Yen, Y.-M. Jeng, C.-C. Chang, C.-Y. Hsieh, L.-H. Wei, P.-C. Yang, and M.-L. Kuo Cyclooxygenase-2 Induces EP1- and HER-2/Neu-Dependent Vascular Endothelial Growth Factor-C Up-Regulation: A Novel Mechanism of Lymphangiogenesis in Lung Adenocarcinoma Cancer Res., January 15, 2004; 64(2): 554 - 564. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |